Does hepatitis G virus cause significant clinical liver disease?

Area of Science:

• Virology and Hepatology
• Infectious Diseases

Background:

• The newly discovered Hepatitis G virus (HGV) has an unknown role in liver disease pathogenesis and clinical significance.
• Current detection methods for HGV RNA rely on costly and time-consuming RT-PCR, as reliable immunoassays are unavailable.
• HGV exhibits worldwide distribution, with significant prevalence in blood donors, yet infections are generally asymptomatic.

Purpose of the Study:

• To investigate the clinical significance and etiological role of Hepatitis G virus (HGV) in liver diseases.
• To understand HGV's prevalence, transmission, and co-infection patterns with other hepatitis viruses.

Main Methods:

• Detection of viral RNA using reverse transcription-polymerase chain reaction (RT-PCR).
• Analysis of prevalence in blood donors and high-risk populations.
• Evaluation of co-infection rates with Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV).

Main Results:

• HGV is globally distributed, infecting up to 5% of voluntary and 12.9% of commercial blood donors.
• HGV frequently co-infects with HCV or HBV, with symptoms mirroring the primary infection.
• HGV infections appear mild, with no unambiguous evidence linking it to severe acute or chronic liver disease or hepatocellular carcinoma.

Conclusions:

• Hepatitis G virus (HGV) infections are common but generally asymptomatic and mild.
• Further research is necessary to establish HGV's definitive role in liver disease.
• Routine screening of blood donors for HGV RNA is not currently recommended.